SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-209158
Filing Date
2013-05-09
Accepted
2013-05-09 08:02:05
Documents
4
Period of Report
2013-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d534077d8k.htm 8-K 15979
2 EX-99.1 d534077dex991.htm EX-99.1 71154
3 GRAPHIC g534077g20o16.jpg GRAPHIC 10863
4 GRAPHIC g534077g92x47.jpg GRAPHIC 6184
  Complete submission text file 0001193125-13-209158.txt   112196
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 13826542
SIC: 2834 Pharmaceutical Preparations